Yao KM - Search Results

1

Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells.

Chan DW, Liu VW, Leung LY, Yao KM, Chan KK, Cheung AN, Ngan HY. Chan DW, et al. Among authors: yao km. J Pathol. 2011 Dec;225(4):525-34. doi: 10.1002/path.2901. Epub 2011 Jun 10. J Pathol. 2011. PMID: 21661123

2

Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.

Chan DW, Liu VW, Tsao GS, Yao KM, Furukawa T, Chan KK, Ngan HY. Chan DW, et al. Among authors: yao km. Carcinogenesis. 2008 Sep;29(9):1742-50. doi: 10.1093/carcin/bgn167. Epub 2008 Jul 16. Carcinogenesis. 2008. PMID: 18632752

3

Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.

Tam CW, Chan KW, Liu VW, Pang B, Yao KM, Shiu SY. Tam CW, et al. Among authors: yao km. J Pineal Res. 2008 Nov;45(4):403-12. doi: 10.1111/j.1600-079X.2008.00608.x. Epub 2008 Jul 10. J Pineal Res. 2008. PMID: 18637986

4

LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.

Li C, Liu VW, Chan DW, Yao KM, Ngan HY. Li C, et al. Among authors: yao km. Int J Gynecol Cancer. 2012 Jan;22(1):15-22. doi: 10.1097/IGC.0b013e3182322834. Int J Gynecol Cancer. 2012. PMID: 22080879

5

Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemoprevention and therapy.

Shiu SY, Leung WY, Tam CW, Liu VW, Yao KM. Shiu SY, et al. Among authors: yao km. J Pineal Res. 2013 Jan;54(1):69-79. doi: 10.1111/j.1600-079X.2012.01026.x. Epub 2012 Aug 1. J Pineal Res. 2013. PMID: 22856547

6

FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c.

Lam AK, Ngan AW, Leung MH, Kwok DC, Liu VW, Chan DW, Leung WY, Yao KM. Lam AK, et al. Among authors: yao km. Front Oncol. 2013 Jan 31;3:11. doi: 10.3389/fonc.2013.00011. eCollection 2013. Front Oncol. 2013. PMID: 23386997 Free PMC article.

7

Activation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascade.

Yung MM, Chan DW, Liu VW, Yao KM, Ngan HY. Yung MM, et al. Among authors: yao km. BMC Cancer. 2013 Jul 3;13:327. doi: 10.1186/1471-2407-13-327. BMC Cancer. 2013. PMID: 23819460 Free PMC article.

8

Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer.

Li C, Liu VW, Chiu PM, Yao KM, Ngan HY, Chan DW. Li C, et al. Among authors: yao km. Mol Cancer. 2014 Mar 6;13:49. doi: 10.1186/1476-4598-13-49. Mol Cancer. 2014. PMID: 24602453 Free PMC article.

9

Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.

Cai PC, Shi L, Liu VW, Tang HW, Liu IJ, Leung TH, Chan KK, Yam JW, Yao KM, Ngan HY, Chan DW. Cai PC, et al. Among authors: yao km. Oncotarget. 2014 Sep 15;5(17):7549-62. doi: 10.18632/oncotarget.2273. Oncotarget. 2014. PMID: 25277189 Free PMC article.

10

Novel Nuclear Partnering Role of EPS8 With FOXM1 in Regulating Cell Proliferation.

Ngan AWL, Grace Tsui M, So DHF, Leung WY, Chan DW, Yao KM. Ngan AWL, et al. Among authors: yao km. Front Oncol. 2019 Mar 19;9:154. doi: 10.3389/fonc.2019.00154. eCollection 2019. Front Oncol. 2019. PMID: 30941306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page